Settings in which to vaccinate. Low disease burden states are optimal settings for vaccination, minimizing the immunosuppressive milieu of the microenvironment that characterizes advanced malignancy. In the setting of more advanced disease states, combination therapies are critical, in order to overcome tumor-mediated immunosuppression. CART, chimeric antigen receptor T; CR1, complement receptor type 1.